Pharmacy Site File

As the durvalumab and tremelimumab Investigator Brochures contain confidential information, they are kept within the Member's Area of the website. Please contact the RAMPART Team ( if you do not have the login details but require access to these documents.

  Current Version Previous Versions
Pharmacy Manual v4.0 (14-Feb-2020) v3.0 (01-Jul-2019)v2.0 (20-May-2019)v1.0 (31-May-2018)
Drug Supply Management System User Guide v1.0 (31-May-2018)  
Durvalumab Sample Label (Carton) 04-Sep-2020 11-Dec-2019, 02-Jan-2018
Durvalumab Sample Label (Vial) 04-Sep-2020 18-Dec-2019, 01-Mar-2018
Tremelimumab Sample Label (Carton) 13-Nov-2020 04-Sep-2020, 11-Dec-2019, 14-Jan-2019, 01-Feb-2018
Tremelimumab Sample Label (Vial) 17-Sep-2020 17-Dec-2019, 08-Jan-2019, 01-Mar-2018


Durvalumab Tremelimumab
19705.1/1 (expired Oct-2019) 19705.2/1 (expired Oct-2018)
19705.5/1 (expired Feb-2020) 19705.3/1 (expired Jun-2019)
19705.6/1 (current) 19705.4/1 (expired Feb-2020)
19705.9/1 (current) 19705.7/1 (expired Dec-2021)
19705.10/1 (current) 19705.11/1 (expired Jan-2023)
19705.13/1 (current) 19705/15.1 (expired Jan-2023)
19705.14/1 (current) 19705/17.1 (current)


  Current Version Previous Versions
Pharmacy Delegation Log v2.0 (27-Sep-2018) v1.0 (31-May-2018)
Site Personnel List v1.0 (31-May-2018)  
PSF Self-Assessment Form v6.0 (28-Jun-2021) v5.0 (07-Sep-2020), v4.0 (29-Jan-2020)v3.0 (01-Jul-2019)v2.0 (31-May-2019)v1.0 (31-May-2018)
Pharmacy Declaration v1.0 (31-May-2018)  
Site Activation Checklist v1.0 (31-May-2018)  


  Current Version Previous Versions
Training Slides v1.0 (31-May-2018)  
Training Log v1.0 (31-May-2018)